Phase I Study of a Monoclonal Antibody for Treatment of Advanced Adenocarcinomas

This study has been completed.

Study NCT00051675 Information provided by XOMA (US) LLC

First Received: January 14, 2003 Last Updated: June 23, 2005 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	September 2003
Estimated Primary Completion Date:	No date given